Michael Paskind

8.0k total citations · 4 hit papers
33 papers, 6.4k citations indexed

About

Michael Paskind is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Michael Paskind has authored 33 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Hematology and 10 papers in Immunology. Recurrent topics in Michael Paskind's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Michael Paskind is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Michael Paskind collaborates with scholars based in United States, Germany and Australia. Michael Paskind's co-authors include David Baltimore, George D. Yancopoulos, Stephen Desiderio, Frederick W. Alt, Robert Kamen, Daniel E. Tracey, Subhashis Banerjee, Winnie W. Wong, Alfred L.M. Bothwell and Thereza Imanishi‐Kari and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Michael Paskind

33 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock

1995 1.2k citations Ping Li, Hamish Allen et al. Cell profile →
Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN- γ production

1997 1.0k citations Tariq Ghayur, Subhashis Banerjee et al. Nature profile →
Heavy chain variable region contribution to the NPb family of antibodies: somatic mutation evident in a γ2a variable region

1981 598 citations Alfred L.M. Bothwell, Michael Paskind et al. Cell profile →
Preferential utilization of the most JH-proximal VH gene segments in pre-B-cell lines

1984 549 citations Michael Paskind, David Baltimore et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Paskind United States	27	3.7k	2.9k	1.1k	773	765	33	6.4k
Richard Tizard United States	41	6.1k 1.7×	3.3k 1.1×	1.2k 1.0×	657 0.8×	1.7k 2.2×	56	11.8k
Edward E. Max United States	40	2.7k 0.7×	2.7k 0.9×	1.4k 1.2×	301 0.4×	504 0.7×	78	5.6k
R. Duncan Campbell United Kingdom	40	2.7k 0.7×	2.9k 1.0×	468 0.4×	858 1.1×	1.0k 1.3×	84	6.0k
J. Donald Capra United States	48	3.3k 0.9×	5.2k 1.8×	3.6k 3.1×	696 0.9×	821 1.1×	185	9.3k
Donald Dowbenko United States	34	3.1k 0.9×	1.4k 0.5×	745 0.6×	322 0.4×	401 0.5×	50	5.5k
Kenneth B. Marcu United States	49	5.1k 1.4×	2.6k 0.9×	924 0.8×	449 0.6×	914 1.2×	122	8.6k
Charles Hannum United States	24	1.9k 0.5×	3.3k 1.1×	1.2k 1.0×	748 1.0×	472 0.6×	38	5.7k
Matthias Wabl United States	41	2.7k 0.7×	3.0k 1.0×	1.3k 1.1×	208 0.3×	505 0.7×	127	5.6k
Susan O. Sharrow United States	49	2.0k 0.5×	6.0k 2.1×	1.4k 1.2×	573 0.7×	543 0.7×	134	8.4k
G. G. B. Klaus Tanzania	47	2.0k 0.6×	4.6k 1.6×	1.3k 1.1×	353 0.5×	337 0.4×	140	6.9k

Countries citing papers authored by Michael Paskind

Since Specialization

Citations

This map shows the geographic impact of Michael Paskind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Paskind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Paskind more than expected).

Fields of papers citing papers by Michael Paskind

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Paskind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Paskind. The network helps show where Michael Paskind may publish in the future.

Co-authorship network of co-authors of Michael Paskind

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Paskind. A scholar is included among the top collaborators of Michael Paskind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Paskind. Michael Paskind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paskind, Michael, et al.. (2000). Structure and promoter activity of the mouse CDC25A gene. Mammalian Genome. 11(12). 1063–1069. 7 indexed citations

Ding, Isabelle, Eddy Bruyns, Ping Li, et al.. (1999). Biochemical and functional analysis of mice deficient in expression of the CD45-associated phosphoprotein LPAP. European Journal of Immunology. 29(12). 3956–3961. 21 indexed citations

Jiang, Xin, et al.. (1998). Expression and regulation of mRNA for distinct isoforms of cAMP-specific PDE-4 in mitogen-stimulated and leukemic human lymphocytes. Cell Biochemistry and Biophysics. 28(2-3). 135–160. 30 indexed citations

Musci, Michael A., David G. Motto, Michael Paskind, et al.. (1997). Molecular Cloning of SLAP-130, an SLP-76-associated Substrate of the T Cell Antigen Receptor-stimulated Protein Tyrosine Kinases. Journal of Biological Chemistry. 272(18). 11674–11677. 221 indexed citations

Ghayur, Tariq, Subhashis Banerjee, Margaret Hugunin, et al.. (1997). Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN- γ production. Nature. 386(6625). 619–623. 1037 indexed citations breakdown →

Epstein, Paul M., et al.. (1996). INHIBITION OF CALMODULIN-DEPENDENT PHOSPHODIESTERASE INDUCES APOPTOSIS IN HUMAN LEUKEMIC CELLS. Biochemical Society Transactions. 24(4). 596S–596S. 2 indexed citations

Jiang, Xin, et al.. (1996). Inhibition of calmodulin-dependent phosphodiesterase induces apoptosis in human leukemic cells.. Proceedings of the National Academy of Sciences. 93(20). 11236–11241. 70 indexed citations

Li, Ping, Hamish Allen, Subhashis Banerjee, et al.. (1995). Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell. 80(3). 401–411. 1225 indexed citations breakdown →

Kamens, Joanne, Michael Paskind, Margaret Hugunin, et al.. (1995). Identification and Characterization of ICH-2, a Novel Member of the Interleukin-1β-converting Enzyme Family of Cysteine Proteases. Journal of Biological Chemistry. 270(25). 15250–15256. 238 indexed citations

10.

Andersen, Robert A., Gary W. Saunders, Michael Paskind, & Julianne P. Sexton. (1993). ULTRASTRUCTURE AND 18S _RRNA GENE SEQUENCE FOR PELAGOMONAS CALCEOLATA GEN. ET SP. NOV. AND THE DESCRIPTION OF A NEW ALGAL CLASS, THE PELAGOPHYCEAE CLASSIS NOV.¹. Journal of Phycology. 29(5). 701–715. 197 indexed citations

11.

Jackson, Peter K., Michael Paskind, & David Baltimore. (1993). Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl.. PubMed. 8(7). 1943–56. 33 indexed citations

12.

Bernards, A., Michael Paskind, & David Baltimore. (1988). Four murine c-abl mRNAs arise by usage of two transcriptional promoters and alternative splicing.. PubMed. 2(4). 297–304. 29 indexed citations

13.

Bernards, André, Charles M. Rubin, Carol A. Westbrook, Michael Paskind, & David Baltimore. (1987). The First Intron in the Human c- abl Gene Is at Least 200 Kilobases Long and Is a Target for Translocations in Chronic Myelogenous Leukemia. Molecular and Cellular Biology. 7(9). 3231–3236. 32 indexed citations

14.

Bernards, A., Charles M. Rubin, C A Westbrook, Michael Paskind, & David Baltimore. (1987). The first intron in the human c-abl gene is at least 200 kilobases long and is a target for translocations in chronic myelogenous leukemia.. Molecular and Cellular Biology. 7(9). 3231–3236. 148 indexed citations

15.

Ben‐Neriah, Yinon, André Bernards, Michael Paskind, George Q. Daley, & David Baltimore. (1986). Alternative 5′ exons in c-abl mRNA. Cell. 44(4). 577–586. 250 indexed citations

16.

Latt, S.A., et al.. (1983). Cloning and analysis of reverse transcript P160 genomes of Abelson murine leukemia virus. Journal of Virology. 45(3). 1195–1199. 32 indexed citations

17.

Bothwell, Alfred L.M., Michael Paskind, Richard C. Schwartz, et al.. (1981). Dual expression of λ genes in the MOPC-315 plasmacytoma. Nature. 290(5801). 65–67. 73 indexed citations

18.

Shoemaker, Charles B., Stephen P. Goff, Eli Gilboa, et al.. (1980). Structure of a cloned circular Moloney murine leukemia virus DNA molecule containing an inverted segment: implications for retrovirus integration.. Proceedings of the National Academy of Sciences. 77(7). 3932–3936. 228 indexed citations

19.

Paskind, Michael, Robert A. Weinberg, & David Baltimore. (1975). Dependence of Moloney murine leukemia virus production on cell growth. Virology. 67(1). 242–248. 70 indexed citations

20.

Besmer, Peter, David Smotkin, William A. Haseltine, et al.. (1974). Mechanism of Induction of RNA Tumor Viruses by Halogenated Pyrimidines. Cold Spring Harbor Symposia on Quantitative Biology. 39(0). 1103–1107. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact